Validity of the French Version of the Child's Chronic Rhinosinusitis Questionnaire
NCT ID: NCT04117646
Last Updated: 2025-09-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
89 participants
OBSERVATIONAL
2020-04-06
2020-06-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The objective of the study is to validate the translation of the SN-5 questionnaire in French.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Post-radiotherapy Rhinosinusitis in Children
NCT05454163
Validation of the Chinese Version of the Sinus and Nasal Quality of Life Survey (SN-5)
NCT04836403
Clinical Characteristic of Recurrent Acute Rhinosinusitis in Children
NCT01827176
Evolution of the Endonasal Microbiota in Patients With Chronic Rhinosinusitis
NCT04418622
Development and Validity of the DyNaChron Questionnaire for Chronic Nasal Dysfunction
NCT02879929
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The treatment of chronic rhinosinusitis is mainly medical and includes nose washes with physiological serum, topical or general corticosteroid treatment or antibiotics. Surgical treatments such as adenoidectomy or endonasal functional surgery are reserved for medical treatment failures. According to a European consensus paper of 2012, the surgical strategy of the chronic rhinosinusitis of the child must start with a adenoidectomy with physiological serum washes, and then secondarily a endonasal functional surgery.
The ability of quality of life questionnaires to measure subjective symptoms over a certain length of time can help in the medical decision by determining the benefit of taking care. A single quality questionnaire evaluating the symptoms of chronic rhinosinusitis in children currently exists. It has been validated in English for children aged 2 to 12. It comprises five areas of quality of life, each rated by a score ranging from 1 to 7 : sinus infection, nasal obstruction, allergic symptoms, emotional distress and activity limitation, coupled with an overall assessment of quality of life with an analogue visual scale (score from 1 to 10). This SN-5 (sinus and nasal quality of life survey) score showed excellent statistics of reproducibility, internal validity and ease of response. It is currently used in several international publications evaluating chronic sinus pathology in children.
The objective of the study is to validate the translation of the SN-5 questionnaire in French.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients
Patients of 2 and 12 years of age with chronic rhinosinusitis.
Sinus and nasal quality of life survey questionnaire (SN-5)
Subjects respond to the translated questionnaire twice at 15 days apart.
Controls
Subjects of 2 and 12 years of age without chronic rhinosinusitis.
Sinus and nasal quality of life survey questionnaire (SN-5)
Subjects respond to the translated questionnaire twice at 15 days apart.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sinus and nasal quality of life survey questionnaire (SN-5)
Subjects respond to the translated questionnaire twice at 15 days apart.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subjects between 2 and 12 years of age Patients : - Patients followed in consultation at Necker Hospital in pediatric department of otolaryngology and cervico-facial surgery for chronic rhinosinusitis (rhinosinusitis more than 12 weeks)
Controls :
\- Subject without chronic rhinosinusitis at the time of inclusion and without chronic rhinitis history
Exclusion Criteria
2 Years
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
URC-CIC Paris Descartes Necker Cochin
OTHER
Assistance Publique - Hôpitaux de Paris
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nicolas Leboulanger, MD PhD
Role: PRINCIPAL_INVESTIGATOR
Assistance Publique - Hôpitaux de Paris
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
AP-HP, Hôpital Necker-Enfants Malades
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Gargula S, Luscan R, Drummond D, Denoyelle F, Couloigner V, Leboulanger N, Simon F. French translation and validation of the Sinus and Nasal Quality of Life Survey (SN-5) in children. Int J Pediatr Otorhinolaryngol. 2021 Jun;145:110706. doi: 10.1016/j.ijporl.2021.110706. Epub 2021 Apr 6.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ID RCB : 2019-A00387-50
Identifier Type: OTHER
Identifier Source: secondary_id
APHP190791
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.